Skip to main content

Open Therapeutics Chair and CEO to Lead Decentralized Science (DeSci) and Open Science Panel at Devconnect Week, Amsterdam, Neatherlands, Wednesday, April 20, 2022.

 

 

The Potential Impact of Decentralized Autonomous Organizations (DAO) to Open Science and Open Access.

Cincinnati, OH — April 11th, 2022 — Open Therapeutics, an open science company, announces its Chair and interim CEO, Jason E. Barkeloo, will lead an open science, open access, and DAO panel discussion at Devconnect Week, April 18th – April 25th, Beurs Van Berlage, Netherlands, entitled, “The Potential Impact of Decentralized Autonomous Organizations (DAO) to Open Science and Open Access”.

Devconnect is an in-person gathering that will feature independent Ethereum blockchain events as part of ETHAmsterdam.

Devconnect will host DeSci Day on April 20th, 2022, at the BOOM Theatre. The event will include talks, panels, pitches and demos from projects and leaders in the DeSci space, along with social events in the evening. Panel discussions will address the link between Decentralized Autonomous Organizations (DAOs), social impact, and scientific innovations.

More about Devconnect, 18-25 April:  https://devconnect.org.

More about DeSci Day, April 20:  https://www.desci.community.

More about ETHAmsterdam, 22-24 April: https://amsterdam.ethglobal.com.

Open Therapeutics’ mission is enabling the global research community to positively impact human, animal, plant, and global environmental health. Therapoid.net is its free open science platform for the public, researchers, and students. It provides grant funding, equipment, technologies, intellectual properties, forums, a manuscript review tool, and ScienceCoins cryptocurrency awards.

As scientists and students collaborate within the free Therapoid scientific platform, they gain ScienceCoins awards. One might think of ScienceCoins as “Bitcoin for scientists.”

For a limited time, when students and researchers freely register, they gain complimentary ScienceCoins.

According to Open Therapeutics founder, Jason E. Barkeloo, “I am proud to represent Open Therapeutics in its leadership of open science, and its support pillars of DeSci and open access, which are reaching a tipping point for global acceptance.”

This event is one of a future series of events to lead the open science, open access, and DeSci adoption.

* The complimentary ScienceCoins awards are available for only a limited time and are open to any qualified registrant.

About Open Therapeutics 
The Company freely provides the scientific community the Therapoid™ platform; an open science collaboration ecosystem that puts scientists and students at the center of research for positively impacting human, animal, plant, and global environmental health.  Therapoid freely provides technologies, intellectual properties (IP), grant funding, equipment, forums, manuscript review tool, career and academic opportunities, and ScienceCoins cryptocurrency awards. Through creating the world’s biggest think tank, members who openly share can be seen by recruiters for academic and career opportunities. This can be particularly beneficial to those in economically developing areas of Africa, Asia, and Latin America.

 

Media Contact:

Jason E. Barkeloo, Founder/Chair

Open Therapeutics

https://Therapoid.net

Info@OpenTherapeutics.org

Twitter: https://twitter.com/OpenTherapeutic

LinkedIn: https://www.linkedin.com/company/10851290

Telegram: https://t.me/Therapoid

 

Our Effort

Open Therapeutics is a major backer of open science and open access efforts.

Open Therapeutics freely provides to science, technology, engineering, and math (STEM) scientists, or another other seriously interested persons, intellectual properties (patents, etc.), grant funding, lab equipment, document development tools, and preprint server in a collaboration platform (Therapoid™).

When the researchers advance the intellectual properties, s/he gains ScienceCoins™; a blockchain-based cryptocurrency.